Internal Medicine, Hepatology · Houston, TX
NPI
1821069162
Since 2006
Specialty
Internal Medicine, Hepatology
Code 207RI0008X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
1200 Binz St Ste 850
Houston, TX, 77004
Phone (713) 794-0700
Groups this clinician bills Medicare through
Medicare paid, 2024
$162K
1,454 services
Medicare patients, 2024
525
Average age 71
Drug cost, 2024
$2.6M
2,967 prescriptions
Company payments, 2025
$40K
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Joseph S Galati was code 99233 (hospital e&m - subsequent), 337 times for 85 patients. In total Joseph S Galati billed 1,454 services in 24 codes, and Medicare paid $162K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-12-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 337 | 85 | $92.86 | $31K |
| 76700 Ultrasound - Abdomen and Pelvis | Office | 193 | 183 | $90.98 | $18K |
| 93975 Duplex Scan - Extremity Arteries | Office | 190 | 181 | $204.04 | $39K |
| 91200 Standard X-ray | Office | 163 | 162 | $23.41 | $3,816 |
| 99223 Hospital E&M - Initial | Facility | 117 | 73 | $129.81 | $15K |
| 99291 Critical Care E&M | Facility | 116 | 34 | $169.15 | $20K |
| 43235 Upper GI Endoscopy | Facility | 65 | 63 | $86.96 | $5,653 |
| 99214 Office E&M - Established | Office | 56 | 48 | $74.33 | $4,162 |
| 43239 Upper GI Endoscopy | Facility | 45 | 45 | $95.91 | $4,316 |
| 99213 Office E&M - Established | Office | 30 | 28 | $57.46 | $1,724 |
| 45380 Lower GI Endoscopy - Other | Facility | 26 | 26 | $138.13 | $3,591 |
| 99215 Office E&M - Established | Office | 23 | 12 | $110.05 | $2,531 |
| G0121 Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | Facility | 19 | 19 | $178.90 | $3,399 |
| 45385 Colonoscopy - Lesion Removal | Facility | 15 | 15 | $194.27 | $2,914 |
| 99204 Office E&M - New | Office | 14 | 14 | $116.53 | $1,631 |
By year: 2022 $520K for 4,281 services; 2023 $470K for 4,060 services; 2024 $162K for 1,454 services.
Medicare prescription drug claims, 2024
In 2024, the drug Joseph S Galati prescribed most often to Medicare patients was Xifaxan (Rifaximin), with 331 prescriptions and refills. In total Joseph S Galati wrote 2,967 Medicare prescriptions that cost $2.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xifaxan Rifaximin | 331 | 359 | 63 | $1.1M |
| Spironolactone Generic | 272 | 573 | 99 | $3,729 |
| Furosemide Generic | 262 | 556 | 106 | $1,221 |
| Lactulose Generic | 251 | 449 | 113 | $10K |
| Ursodiol Generic | 247 | 552 | 74 | $43K |
| Pantoprazole Sodium Generic | 226 | 494 | 80 | $2,699 |
| Famotidine Generic | 123 | 279 | 47 | $1,277 |
| Carvedilol Generic | 83 | 149 | 33 | $311 |
| Azathioprine Generic | 65 | 169 | 19 | $3,513 |
| Constulose Lactulose | 64 | 91 | 34 | $2,500 |
| Omeprazole Generic | 63 | 129 | 17 | $991 |
| Tenofovir Disoproxil Fumarate Generic | 62 | 126 | 12 | $6,004 |
| Prednisone Generic | 60 | 115 | 22 | $376 |
| Sod Sulf-Potass Sulf-Mag Sulf Sodium, Potassium,mag Sulfates | 42 | 42 | 40 | $2,605 |
| Vemlidy Tenofovir Alafenamide | 38 | 51 | Under 11 | $68K |
Brand drugs: 679 claims; generic drugs: 2,288 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Joseph S Galati $40K ($40K in general payments such as food, travel and fees) from 14 companies. The largest payer was Madrigal Pharmaceuticals with $19K.
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals MDGL | 36 | $19K |
| Bausch Health US, LLC BHC | 8 | $9,105 |
| Gilead Sciences, Inc. GILD | 20 | $5,476 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 21 | $3,747 |
| Intercept Pharmaceuticals, Inc. | 4 | $1,855 |
| Echosens North America, Inc. | 1 | $386 |
| Ipsen Biopharmaceuticals, Inc IPN.PA | 9 | $202 |
| Abbvie Inc. ABBV | 4 | $79.38 |
| Novo Nordisk Inc NVO | 3 | $59.27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $29.98 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.